European Movers: Next (NXT LN) +2.8%, Prudential (PRU LN) +2.3%, Bayer (BAYN GY) +0.8%, Holcim (HOLN SW) +0.6%, AB InBev (ABI BB) -0.7%, Brenntag (BNR GY) -1.9%, Adidas (ADS GY) -4.4%

AB InBev (ABI BB) - Co. reacquired 49.9% in US metal container plants for USD 3bln; deal includes the acquisition of seven plants across six different states. The Co. is expected to fund the deal with cash, and exp. to close in Q1'26. 

Adidas (ADS GY) downgraded to Underperform from Buy at Bank of America.

Bayer (BAYN GY) - Co. receives breakthrough designation in the US and China for sevabertinib as a first-line treatment for patients with HER2-mutant non-small cell lung cancer.

Brenntag (BNR GY) downgraded at Morgan Stanley.

Holcim (HOLN SW) - Co. said it had completed the acquisition of Alkern. Value-accretive acquisition to deliver run-rate EBITDA  synergies of EUR 11 million in year three, EPS accretive in year one. Acquisition to advance Holcim's NextGen Growth 2030 target  for Building Solutions to reach 50% of 2030 net sales. 

Next (NXT LN) - Q4 Trading Update (GBP): Full Price Sales +10.6% Y/Y (9-weeks to 27 Dec), vs guidance of +7%. UK Sales +5.9%; International Sales +38.3%. Guidance: Increases FY PBT guidance to 1.15bln (prev. guided 1.135mln). Full Price Sales 5.60bln (prev. guided 5.55bln).

Prudential (PRU LN) - Co. launches a USD 1.2bln share buyback programme.

The varied stock movements show market reactions to corporate earnings and strategic updates within key European firms. Next’s sales growth and improved profit guidance indicate strong performance, while Adidas facing a downgrade suggests investor caution in the retail space. Overall, this highlights diverse sector dynamics in European equities, impacting investor sentiment and positioning in the markets.